Physician profile
Gordon S Warner
NPI 1194754788
$100,326.34
in general payments reported to CMS, 2019-2025
49 companies · $5,153 in 2025
The $5,153 reported for 2025 was more than what 93% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $26K · 2021: $4,868 · 2022: $11K · 2023: $3,282 · 2024: $3,166 · 2025: $5,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $970 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,421.85 |
| Travel and Lodging | $970.35 |
| Education | $207.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $35,272.33 | 2019-2024 | Yupelri |
| Glaxosmithkline, LLC. | $30,882.51 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Grifols USA, LLC | $13,401.43 | 2019-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $4,284.01 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Jazz Pharmaceuticals INC. | $2,082.00 | 2019-2025 | |
| Inspire Medical Systems, INC. | $1,730.58 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,712.04 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Harmony Biosciences LLC | $1,301.05 | 2020-2025 | Wakix |
| Insmed, INC. | $1,118.70 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $1,069.60 | 2020-2025 | Glassia |
| Genzyme Corporation | $970.48 | 2022-2025 | |
| Axsome Therapeutics, INC. | $760.31 | 2022-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $660.41 | 2019-2025 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $607.74 | 2023-2025 | Lumryz |
| Viiv Healthcare Company | $600.00 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $421.60 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Sunovion Pharmaceuticals INC. | $417.73 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $376.12 | 2021-2025 | Acthar |
| Corium, LLC | $355.67 | 2022-2025 | Azstarys |
| Astellas Pharma US INC | $262.35 | 2019-2020 | |
| Fisher & Paykel Healthcare INC | $234.66 | 2022-2024 | Fisher & Paykel Healthcare |
| Genentech USA, INC. | $233.20 | 2019-2021 | |
| Amgen INC. | $231.43 | 2022-2025 | Tezspire |
| Idorsia Pharmaceuticals US INC | $215.93 | 2023-2025 | Quviviq, Quviviq |
| Merck Sharp & Dohme LLC | $188.48 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $118.71 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.75 | 2025 | |
| Ani Pharmaceuticals, INC. | $83.61 | 2022-2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $69.73 | 2025 | Zepbound |
| Gilead Sciences, INC. | $66.49 | 2021 | |
| 3b Medical, INC. | $59.92 | 2023-2025 | Luna |
| Eisai INC. | $45.28 | 2020-2021 | |
| Viatris Specialty LLC | $43.06 | 2025 | Yupelri |
| Baxter Healthcare | $42.51 | 2023 | Hillrom - Life 2000 Ventilation System |
| Arbor Pharmaceuticals, INC. | $40.50 | 2019 | |
| Ironshore Pharmaceuticals INC. | $38.54 | 2019 | |
| Advanced Respiratory, INC | $34.43 | 2020 | |
| Vifor Pharma, INC. | $29.39 | 2024 | Zemaira |
| United Therapeutics Corporation | $28.10 | 2024 | Tyvaso |
| Inogen, INC. | $27.20 | 2022 | |
| Csl Behring | $24.46 | 2020 | |
| Verona Pharma, INC. | $19.55 | 2025 | Ohtuvayre |
| Tris Pharma INC | $18.98 | 2023 | Dyanavel Xr |
| Pulmonx Corporation | $16.95 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.17 | 2023 | Edarbi |
| Abbvie INC. | $12.65 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.